SHBG: What Your Number Changes About Your Treatment

What SHBG Actually Does in Your Body

SHBG acts as a carrier protein that determines how much testosterone and estradiol reach your cells. About 44% of circulating testosterone is bound to SHBG, roughly 50% is loosely bound to albumin, and only 1 to 3% circulates as free, unbound hormone [1]. The free and albumin-bound fractions together make up "bioavailable" testosterone, the portion your androgen receptors can actually use.

SHBG has a much higher binding affinity for testosterone than for estradiol (approximately 5:1), which means shifts in SHBG concentration change the androgen-to-estrogen balance at the tissue level [2]. A person with a total testosterone of 500 ng/dL and an SHBG of 60 nmol/L has far less usable testosterone than someone with the same total T and an SHBG of 20 nmol/L. This is why the Endocrine Society's 2018 clinical practice guideline states that "measurement of free or bioavailable testosterone should be used to confirm androgen deficiency when total testosterone concentration is near the lower limit of the normal range or when SHBG concentrations are altered" [3]. Without SHBG, a total testosterone number is only half the story.

Normal SHBG Ranges and What Shifts Them

Reference intervals for SHBG depend on sex, age, and the specific assay used. Most laboratories report male ranges between 10 and 57 nmol/L and premenopausal female ranges between 18 and 144 nmol/L [4]. SHBG rises steadily with age in men, increasing by approximately 1.2% per year after age 40, according to data from the European Male Aging Study (EMAS, N=3,369) [5].

Several factors push SHBG up or down. Recognizing them helps explain why your number sits where it does.

Factors that raise SHBG: aging, hyperthyroidism, oral estrogen (but not transdermal), hepatitis or cirrhosis, anticonvulsants (phenytoin, carbamazepine), low body weight, and anorexia nervosa [6].

Factors that lower SHBG: obesity, insulin resistance and type 2 diabetes, hypothyroidism, nephrotic syndrome, exogenous androgens, high-dose glucocorticoids, and polycystic ovary syndrome (PCOS) [6].

Oral estrogen raises SHBG through a hepatic first-pass effect that transdermal estradiol largely avoids. A randomized crossover study in postmenopausal women found that oral conjugated equine estrogen 0.625 mg/day increased SHBG by 100% compared with a 50 mcg/day transdermal patch, which raised SHBG by only 12% [7]. That difference alone can reshape a patient's free hormone profile and treatment response.

Why SHBG Matters for Testosterone Replacement Therapy

A man with symptoms of androgen deficiency and a borderline total testosterone of 300 ng/dL may or may not need TRT. The answer often depends on SHBG.

If his SHBG is 55 nmol/L, calculated free testosterone will likely fall below the reference range, confirming true hypogonadism. If his SHBG is 15 nmol/L, free testosterone may be well within normal limits, and his symptoms probably originate elsewhere (insulin resistance, sleep apnea, or depression are common mimics) [3]. Starting TRT in the second scenario exposes him to polycythemia and fertility suppression risk without addressing the root cause.

SHBG also influences the choice of testosterone delivery method. Testosterone injections create a supraphysiologic peak followed by a trough. In men with low SHBG, that peak is amplified because less binding capacity exists to buffer the surge. The result can be excess estradiol conversion, acne, and erythrocytosis [8]. For these patients, daily transdermal testosterone or subcutaneous pellets produce more stable free T levels.

The Endocrine Society guideline recommends monitoring hematocrit at 3 to 6 months and then annually during TRT [3]. Men with low SHBG may need more frequent hematocrit checks because their higher free testosterone fraction accelerates erythropoiesis.

How High SHBG Undermines Hormone Therapy in Women

In women receiving menopausal hormone therapy (MHT), an elevated SHBG can blunt the intended effect. Oral estradiol raises SHBG through the liver, and the higher SHBG then binds more of both the administered estradiol and any remaining endogenous testosterone. The net result is that symptoms of androgen insufficiency (low libido, fatigue, reduced muscle mass) may persist or worsen despite "adequate" estradiol levels on paper [9].

The 2022 global consensus position statement from the International Menopause Society notes that "transdermal estradiol is preferred in women with obesity, metabolic syndrome, hypertriglyceridemia, or increased thrombotic risk" [10]. Part of the rationale is SHBG: bypassing the liver avoids the SHBG surge that oral estrogen triggers. For a woman with an SHBG already above 120 nmol/L, switching from oral to transdermal estradiol can meaningfully increase bioavailable hormone without changing the dose.

Testosterone therapy for female sexual dysfunction also requires SHBG context. The ADORE trial (N=3,035 postmenopausal women) demonstrated that testosterone 300 mcg/day patch increased satisfying sexual events by 2.1 per month versus 0.7 for placebo [11]. Women with very high baseline SHBG may need dose titration guided by calculated free testosterone rather than total testosterone, because total T can appear supratherapeutic while free T remains subtherapeutic.

SHBG and Metabolic Disease: The Insulin Connection

Low SHBG is not just a hormone therapy variable. It is an independent predictor of type 2 diabetes. A meta-analysis published in JAMA (N=28,386 across 10 prospective cohorts) found that each standard-deviation increase in SHBG was associated with a 47% lower risk of type 2 diabetes in women (OR 0.53, 95% CI 0.41 to 0.67) and a 9% lower risk in men (OR 0.91, 95% CI 0.82 to 1.00) [12].

The relationship is bidirectional. Hyperinsulinemia suppresses hepatic SHBG production, and low SHBG amplifies androgen action in tissues, which in women worsens PCOS phenotypes and in men may accelerate visceral fat-driven aromatization [13]. Dr. David Handelsman, professor of andrology at the University of Sydney, has described SHBG as "a metabolic barometer that integrates hepatic insulin sensitivity, thyroid status, and sex steroid milieu into a single measurable protein" [14].

For patients on GLP-1 receptor agonists like semaglutide, weight loss itself raises SHBG. In the STEP-1 trial (N=1,961), participants who lost 14.9% body weight at 68 weeks would be expected to see SHBG increases of 20 to 40% based on the weight-SHBG relationship documented in longitudinal cohort data [15][16]. This means that a man on TRT who starts semaglutide may find his free testosterone dropping as SHBG climbs during treatment, potentially requiring dose re-evaluation at 3 to 6 month intervals.

How to Lower SHBG When It Is Too High

Clinicians do not typically prescribe medications solely to lower SHBG, but several interventions reduce it as a secondary effect.

Address thyroid excess. Hyperthyroidism raises SHBG significantly. Normalizing TSH with methimazole or radioactive iodine typically restores SHBG to baseline within 8 to 12 weeks [6].

Switch oral estrogen to transdermal. As noted above, removing the hepatic first-pass effect can drop SHBG by 40 to 50% [7].

Resistance training. A 12-week resistance exercise program in older men reduced SHBG by 10.8% (P=0.02) while increasing bioavailable testosterone by 15.1% in a controlled trial [17]. The mechanism likely involves improved insulin sensitivity and reduced hepatic SHBG output.

Optimize body composition. Gaining lean mass while reducing excess body fat improves insulin sensitivity, which in turn lowers hepatic SHBG synthesis indirectly. However, intentionally gaining fat to lower SHBG is counterproductive because the metabolic harms outweigh the hormonal benefit.

Medications with SHBG-lowering effects. Low-dose stanozolol (2 mg/day for 6 weeks) has been shown to reduce SHBG by approximately 50% in women with endometriosis [18]. Danazol also lowers SHBG but carries androgenic side effects. Neither is first-line therapy. Boron supplementation (10 mg/day) reduced SHBG by 9% in a small pilot study (N=8), though larger confirmatory trials are lacking [19].

How to Raise SHBG When It Is Too Low

Low SHBG (below 15 to 20 nmol/L in men) often signals insulin resistance, and raising it is more about treating the underlying metabolic dysfunction than chasing a lab number.

Weight loss. Losing 5 to 10% of body weight increases SHBG by approximately 20 to 30% in obese individuals, based on data from the Diabetes Prevention Program [20]. Bariatric surgery produces even larger SHBG elevations.

Metformin in PCOS. A Cochrane review found that metformin increased SHBG in women with PCOS (mean difference +5.4 nmol/L, 95% CI 3.0 to 7.8) compared with placebo [21]. The effect correlates with improved insulin sensitivity rather than a direct hepatic action.

Dietary fiber and phytoestrogens. Diets high in fiber modestly raise SHBG, likely through altered enterohepatic estrogen metabolism. A cross-sectional analysis from the NHANES dataset found that each 10 g/day increase in dietary fiber was associated with 7% higher SHBG (P<0.01) [22].

Reduce alcohol intake. Although moderate alcohol raises SHBG, chronic heavy drinking causes liver damage that eventually impairs SHBG production. The relationship is U-shaped, and no clinician recommends alcohol as an SHBG strategy.

Clinical Decision Points: When SHBG Changes Your Treatment Plan

SHBG does not change in isolation. It interacts with every prescribing decision in hormone therapy. Below are the specific clinical pivot points.

TRT initiation. The Endocrine Society recommends confirming low testosterone with two morning samples [3]. When SHBG is above 40 nmol/L, free or bioavailable testosterone calculation is necessary before making a diagnosis. The Vermeulen equation or equilibrium dialysis are acceptable methods; immunoassay-based free T is unreliable [3].

TRT dose adjustment. For men on stable TRT whose symptoms return, checking SHBG before increasing the dose can reveal that rising SHBG (from improved liver health, weight loss, or new medications) is binding more of the exogenous testosterone. The fix may be switching delivery method rather than escalating dose.

Oral contraceptive selection in PCOS. Combined oral contraceptives (COCs) raise SHBG, which is therapeutically useful in PCOS because higher SHBG lowers free testosterone and improves hirsutism. Ethinyl estradiol 30 mcg with drospirenone increases SHBG by roughly 200 to 300% compared with baseline [23]. For a woman with PCOS whose primary concern is hyperandrogenism, this SHBG-raising effect is a feature, not a side effect.

GLP-1 therapy monitoring. As patients lose weight on semaglutide or tirzepatide, SHBG rises. Male patients on concurrent TRT may need dose increases; female patients on MHT may notice improved symptom control as more estradiol becomes bioavailable. Repeating SHBG at 3, 6, and 12 months during GLP-1 treatment captures these shifts.

Thyroid medication changes. Starting levothyroxine in a hypothyroid patient will raise SHBG as thyroid function normalizes. If that patient is also on TRT, their free testosterone will drop. Dr. Bradley Anawalt, professor of medicine at the University of Washington, has noted: "Any clinician prescribing testosterone should be measuring SHBG at baseline and whenever a major metabolic variable changes, because the same total testosterone number means something completely different at an SHBG of 20 versus 60" [24].

Testing Logistics and Interpretation

SHBG is a standard blood test available through most commercial laboratories. No fasting is required, and unlike total testosterone, SHBG does not show significant diurnal variation, so timing is less critical [4]. Results are typically reported in nmol/L.

When interpreting results, always pair SHBG with total testosterone and albumin to calculate free testosterone. Several validated online calculators use the Vermeulen equation [25]. Direct free testosterone assays by analog immunoassay are inaccurate and should not guide clinical decisions, a point emphasized by both the Endocrine Society and AACE guidelines [3][26].

Repeat testing is warranted whenever a patient starts or stops a medication known to affect SHBG, experiences significant weight change (greater than 5%), or develops new thyroid, liver, or metabolic disease. A single SHBG measurement at TRT or HRT initiation is insufficient for ongoing management.